Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Piguet

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Panminerva Medica|September 10, 1999
Utility and complications of permanent venous access devices (PVAD) in oncological treatments. Follow-up of 100 casesY Groebli, P Wutrich, M Safa, et al.
Schweizerische Medizinische Wochenschrift|October 24, 1998
[Post-mortem evaluation following oncologic treatment of the functional and bacteriologic status of 25 permanent venous access devices]Y Groebli, J Bartolomei, P Wüthrich, et al.
Schweizerische Medizinische Wochenschrift|March 20, 1982
[Multicenter study on the status of antibiotic and chemotherapy resistance in Switzerland 1979]W A Vischer, J D Piguet, J S Pitton, et al.
Applied Optics|March 8, 2008
In vivo local determination of tissue optical properties: applications to human brainF Bevilacqua, D Piguet, P Marquet, et al.
Toxicology and Applied Pharmacology|July 27, 2007
MAPK-ERK activation in kidney of male rats chronically fed ochratoxin A at a dose causing a significant incidence of renal carcinomaM Marin-Kuan, S Nestler, C Verguet, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 3, 2007
Induction of Nrf2-mediated cellular defenses and alteration of phase I activities as mechanisms of chemoprotective effects of coffee in the liverC Cavin, M Marin-Kuan, S Langouët, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 28, 2005
A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin a carcinogenicity in ratM Marin-Kuan, S Nestler, C Verguet, et al.
The New England Journal of Medicine|July 12, 1990
Fatal infection with a novel, unidentified mycobacterium in a man with the acquired immunodeficiency syndromeB Hirschel, H R Chang, N Mach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II studyA von Rohr, S-F H Schmitz, A Tichelli, et al.
Nature|May 4, 2007
Chemical characterization of element 112R Eichler, N V Aksenov, A V Belozerov, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Panminerva Medica|September 10, 1999
Utility and complications of permanent venous access devices (PVAD) in oncological treatments. Follow-up of 100 casesY Groebli, P Wutrich, M Safa, et al.
Schweizerische Medizinische Wochenschrift|October 24, 1998
[Post-mortem evaluation following oncologic treatment of the functional and bacteriologic status of 25 permanent venous access devices]Y Groebli, J Bartolomei, P Wüthrich, et al.
Schweizerische Medizinische Wochenschrift|March 20, 1982
[Multicenter study on the status of antibiotic and chemotherapy resistance in Switzerland 1979]W A Vischer, J D Piguet, J S Pitton, et al.
Applied Optics|March 8, 2008
In vivo local determination of tissue optical properties: applications to human brainF Bevilacqua, D Piguet, P Marquet, et al.
Toxicology and Applied Pharmacology|July 27, 2007
MAPK-ERK activation in kidney of male rats chronically fed ochratoxin A at a dose causing a significant incidence of renal carcinomaM Marin-Kuan, S Nestler, C Verguet, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 3, 2007
Induction of Nrf2-mediated cellular defenses and alteration of phase I activities as mechanisms of chemoprotective effects of coffee in the liverC Cavin, M Marin-Kuan, S Langouët, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 28, 2005
A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin a carcinogenicity in ratM Marin-Kuan, S Nestler, C Verguet, et al.
The New England Journal of Medicine|July 12, 1990
Fatal infection with a novel, unidentified mycobacterium in a man with the acquired immunodeficiency syndromeB Hirschel, H R Chang, N Mach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II studyA von Rohr, S-F H Schmitz, A Tichelli, et al.
Nature|May 4, 2007
Chemical characterization of element 112R Eichler, N V Aksenov, A V Belozerov, et al.
Pageof 4